This Week’s Biopharma News: New Approvals, Appeals, and AI - Top-Institutions - MDSpire

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

  • June 2, 2026

  • 5 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Pharmacology
    • Drug Development
    • Clinical Trials

  • #2

    Stanford University/Stanford Health Care
    Stanford University/Stanford Health Care

    Stanford, California

    Key Differentiators

    • Pharmacology
    • Translational Medicine

  • #3

    Tufts Center for the Study of Drug Development
    Tufts Center for the Study of Drug Development

    Medford, Massachusetts

    Key Differentiators

    • Pharmacology
    • Drug Development

  • #4

    The Hastings Center
    The Hastings Center

    Garrison, New York

    Key Differentiators

    • Bioethics
    • Pharmacology

  • #5

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology
    • Pharmacology

Original Source(s)

This Week’s Biopharma News: New Approvals, Appeals, and AI

  • June 2, 2026

Related Content

Combined reconstruction of complex chest wall defects using mesh-supported rigid materials and abdominal flap strategies: a retrospective clinical study

Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells

Insulin-like growth factor 1 receptor regulates breast cancer cell adhesion through beta-1 integrin